Pain News and Research

Latest Pain News and Research

Some Minn. insurers will end certain Medicare plans; Utah issues rule on child-only plans; Fla. law on pain clinics takes effect

Five insurance companies including Minnetonka-based Medica next year will stop providing a particular type of Medicare health plan in much of Minnesota, a state official said Thursday.

4 Oct 2010

Sanofi-aventis publishes Phase III TROPIC study data in The Lancet article

Sanofi-aventis announced today that data from the Phase III TROPIC study, which was the basis for the June 2010 U.S. Food and Drug Administration (FDA) approval of Jevtana (cabazitaxel) Injection, was published in the October 2, 2010 print edition of The Lancet in an article titled "Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial.

4 Oct 2010

Report says drugmakers failing to give Medicaid adequate price data

Drug manufacturers often flout a federal law that requires them to provide the government with pricing data needed to calculate discounts on medications prescribed for poor people under Medicaid, federal investigators say in a new report.

4 Oct 2010

Sculptra dermal filler can make feet feel younger

Most women will sacrifice comfort for fashion, especially when it comes to wearing a gorgeous pair of high heels that make an outfit. Unfortunately, over time, the fat pad at the ball of the foot thins and shifts so bones are not as well padded. Combine these changes with a heel height over two inches and it's a recipe for foot pain. "Now there is an alternative to forsaking your favorite pair of sky high Louboutins, states Dr. Archer.

4 Oct 2010

Suspected hand, foot and mouth disease on Denver flight

Two children arrived on a flight from Mexico to Denver showing symptoms of the contagious illness called ‘hand, foot and mouth’ disease (HFMD) and were checked by paramedics. They were allowed to leave after experts said they were no threat to public health.

4 Oct 2010

CEUS ultrasound offers superior efficacy to CT scans

Contrast-enhanced ultrasound (CEUS) can be used to evaluate and monitor inflammatory bowel disease (IBD) without exposing patients to CT scans or ionizing radiation, according to a report announced today (Friday) at the ICUS Bubble Conference in Chicago.

4 Oct 2010

BMC researchers receive grants to study effectiveness of integrative medicine in underserved patients

Two Boston Medical Center (BMC) researchers have each been awarded grants from the NIH National Center for Complementary and Alternative Medicine (NCCAM) to study the effectiveness of integrative medicine in underserved patients.

4 Oct 2010

Icagen updates status of ICA-105665 clinical development program

Icagen, Inc. today provided an update on the status of the clinical development program for ICA-105665. As previously reported, the Company recently suspended enrollment in the photosensitivity study of ICA-105665.

3 Oct 2010

Shoulder pain costs American health system $7 billion

25 out of 1,000 visits to the family doctor are related to shoulder pain. This is currently the cause of 13% of sick leaves, and it costs the American health system 7 billion dollars.

1 Oct 2010

QRxPharma's A$14 million Placement oversubscribed

QRxPharma Limited has today announced a Placement which raised A$14 million and which was significantly oversubscribed.

1 Oct 2010

AcelRx completes ARX-02 End-of-Phase 2 meeting with FDA for cancer breakthrough pain management system

AcelRx Pharmaceuticals, Inc. today announced that it has completed an End-of-Phase 2 meeting with the US Food and Drug Administration (FDA) for ARX-02, a proprietary Sufentanil NanoTab™ Breakthrough Pain Management System for the treatment of cancer breakthrough pain in opioid-tolerant patients. FDA reviewed a package based on the previously announced positive Phase 2 clinical study results to date for ARX-02 and provided AcelRx with guidance on the Phase 3 program design and NDA requirements.

1 Oct 2010

Healthy respect for flu this season

Flu season officially begins Friday, Oct. 1, and unlike last year's season when shortages lead to rationing, there will be plenty of vaccine on hand for everyone who wants a flu shot.

1 Oct 2010

NIH funds $1.5M for research into prediction of stroke risk in pediatric patients with sickle cell disease

A researcher from the biomedical engineering department operated by Georgia Tech and Emory University has received a $1.5 million NIH Director's New Innovator Award to support a project aimed at reducing the incidence of stroke in children with sickle cell disease. Manu Platt, an assistant professor in the Wallace H. Coulter Department of Biomedical Engineering, will use the National Institutes of Health (NIH) funding to develop models for identifying which children with the disease are at risk for stroke.

1 Oct 2010

New RF detection device may help eliminate retained surgical sponges in patients after surgical procedure

Using the same technology found in clothing tags used in retail store tracking systems, a study from the University of North Carolina at Chapel Hill shows that surgical sponges with implanted radio frequency (RF) tags may be an effective adjunct to manual counting and X-ray detection in preventing sponges from being left behind in patients following a surgical procedure.

1 Oct 2010

Headaches, back pain and arthritis cost companies more than $61 billion per annum

Headaches, back pain, arthritis and other aches distract employees and cost companies more than $61 billion a year in lost productive time, according to a study published in the Journal of the American Medical Association.

1 Oct 2010

RN expert provides an overview on healthcare quality measurement

Students at Louisiana State University today heard an executive with Baton Rouge-based Amedisys talk about how quality is measured in health care and why it should matter to all Americans. Amedisys is the largest home health care and hospice company in the U.S., providing care to more than 35,000 patients every day.

1 Oct 2010

Wenzel Spine receives FDA marketing clearance for VariLift Expandable Interbody Fusion System

Wenzel Spine, Inc., a medical device company focused on offering less invasive, stand-alone alternatives to traditional spinal fusion, today announced they have received 510K clearance to market the VariLift Expandable Interbody Fusion System.

30 Sep 2010

St. Jude Medical receives Japanese approval for Eon Mini spinal cord stimulation system

St. Jude Medical, Inc., a global medical device company, today announced regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) of the Eon Mini™ spinal cord stimulation (SCS) system. The world's smallest, longest-lasting rechargeable neurostimulator, the Eon Mini device is the first rechargeable spinal cord stimulator to be approved for use in Japan.

30 Sep 2010

Teva Pharmaceuticals, OncoGenex initiate SYNERGY Phase 3 trial to evaluate custirsen

Teva Pharmaceuticals Industries Ltd. and OncoGenex Pharmaceuticals, Inc. announced today the initiation of SYNERGY, a global Phase 3 trial evaluating custirsen (also known as OGX-011/TV-1011) as first line therapy for the treatment of castrate-resistant prostate cancer (CRPC).

30 Sep 2010

Best P.A.D. Research Awards honor investigators for research on peripheral arterial disease

The Peripheral Arterial Disease (P.A.D.) Coalition presented the Coalition's second annual Best P.A.D. Research Awards to the top three research papers on P.A.D. published in 2009 at the organization's Seventh Annual Meeting in Alexandria, VA last week. The Best P.A.D. Research Awards honor the work of investigators and acknowledge the creation of new clinical research relevant to the understanding and/or treatment of peripheral arterial disease.

30 Sep 2010

Pain News and Research

Latest Pain News and Research

Some Minn. insurers will end certain Medicare plans; Utah issues rule on child-only plans; Fla. law on pain clinics takes effect

Sanofi-aventis publishes Phase III TROPIC study data in The Lancet article

Report says drugmakers failing to give Medicaid adequate price data

Sculptra dermal filler can make feet feel younger

Suspected hand, foot and mouth disease on Denver flight

CEUS ultrasound offers superior efficacy to CT scans

BMC researchers receive grants to study effectiveness of integrative medicine in underserved patients

Icagen updates status of ICA-105665 clinical development program

Shoulder pain costs American health system $7 billion

QRxPharma's A$14 million Placement oversubscribed

AcelRx completes ARX-02 End-of-Phase 2 meeting with FDA for cancer breakthrough pain management system

Healthy respect for flu this season

NIH funds $1.5M for research into prediction of stroke risk in pediatric patients with sickle cell disease

New RF detection device may help eliminate retained surgical sponges in patients after surgical procedure

Headaches, back pain and arthritis cost companies more than $61 billion per annum

RN expert provides an overview on healthcare quality measurement

Wenzel Spine receives FDA marketing clearance for VariLift Expandable Interbody Fusion System

St. Jude Medical receives Japanese approval for Eon Mini spinal cord stimulation system

Teva Pharmaceuticals, OncoGenex initiate SYNERGY Phase 3 trial to evaluate custirsen

Best P.A.D. Research Awards honor investigators for research on peripheral arterial disease

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Pain News and Research

Latest Pain News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in